Medicine guide
ENRYLAZE
As listed in the register: ENRYLAZE 10 mg/0,5 mL, solution injectable/pour perfusion
10 mg · solution injectable ou pour perfusion
- Prescription only
- Active substance
- Crisantaspase Recombinante
- Made by
- JAZZ PHARMACEUTICALS IRELAND LIMITED (IRLANDE)
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | JAZZ PHARMACEUTICALS IRELAND LIMITED (IRLANDE) |
|---|---|
| Active substance | Crisantaspase Recombinante |
| Strength | 10 mg |
| Form | solution injectable ou pour perfusion |
| Route | intramusculaire;intraveineuse |
| Dispensing (as stated by the register) | réservé à l'usage HOSPITALIER · médicament nécessitant une surveillance particulière pendant le traitement · prescription réservée aux spécialistes et services HEMATOLOGIE · liste I · prescription réservée aux médecins compétents en maladie du sang |
| Marketed | Yes, according to the register |
| Reinforced monitoring | Yes — under reinforced monitoring, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/23/1747 |
| Name in the register | ENRYLAZE 10 mg/0,5 mL, solution injectable/pour perfusion |
| Packs | 3 flacon(s) en verre de 0,5 ml |
| CIS | 67034579 |
| CIP13 | 3400955098683 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).